PIA
BMY icon

Piedmont Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Piedmont Investment Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-267,629
Closed -$14.9M – 90
2020
Q1 		$14.9M Sell
267,629
-62,933
-19% -$3.85M 0.59% 29
2019
Q4 		$21.2M Buy
330,562
+56,258
+21% +$3.22M 0.73% 18
2019
Q3 		$13.9M Buy
274,304
+13,856
+5% +$651K 0.54% 38
2019
Q2 		$11.8M Buy
260,448
+84,934
+48% +$3.96M 0.47% 43
2019
Q1 		$8.37M Buy
175,514
+2,478
+1% +$123K 0.34% 72
2018
Q4 		$8.99M Buy
173,036
+8,632
+5% +$464K 0.43% 51
2018
Q3 		$10.2M Buy
164,404
+8,951
+6% +$531K 0.43% 53
2018
Q2 		$8.6M Sell
155,453
-166,592
-52% -$9M 0.41% 60
2018
Q1 		$20.4M Sell
322,045
-158,314
-33% -$10.2M 0.54% 45
2017
Q4 		$29.4M Sell
480,359
-1,228
-0.3% -$76.8K 0.59% 44
2017
Q3 		$30.7M Buy
481,587
+47,091
+11% +$2.75M 0.65% 40
2017
Q2 		$24.2M Buy
434,496
+79,842
+23% +$4.34M 0.54% 43
2017
Q1 		$19.3M Sell
354,654
-43,342
-11% -$2.38M 0.4% 68
2016
Q4 		$23.3M Sell
397,996
-468,373
-54% -$25.6M 0.48% 61
2016
Q3 		$46.7M Sell
866,369
-105,078
-11% -$6.75M 1.01% 23
2016
Q2 		$71.4M Buy
971,447
+12,328
+1% +$871K 1.47% 13
2016
Q1 		$61.3M Buy
959,119
+68,406
+8% +$4.31M 1.29% 16
2015
Q4 		$61.3M Buy
890,713
+42,144
+5% +$2.79M 1.29% 16
2015
Q3 		$50.2M Buy
848,569
+485,128
+133% +$30.8M 1.13% 20
2015
Q2 		$24.2M Buy
363,441
+362,073
+26,467% +$23.9M 0.51% 59
2015
Q1 		$88.2K Hold
1,368
– – 0.01% 158
2014
Q4 		$80.8K Hold
1,368
– – ﹤0.01% 167
2014
Q3 		$70K Sell
1,368
-38
-3% -$1.9K ﹤0.01% 171
2014
Q2 		$68.2K Sell
1,406
-483
-26% -$23.8K ﹤0.01% 171
2014
Q1 		$98.1K Sell
1,889
-941
-33% -$50.1K 0.01% 157
2013
Q4 		$150K Sell
2,830
-104
-4% -$5.3K 0.01% 144
2013
Q3 		$136K Buy
2,934
+2,207
+304% +$96.9K 0.01% 146
2013
Q2 		$32.5K Buy
+727
New +$31.6K ﹤0.01% 233

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Piedmont Investment Advisors's BMY Position: Q2 2020 in Review

Piedmont Investment Advisors sold out of Bristol-Myers Squibb (BMY) in Q2 2020, closing a stake of 267,629 shares — an estimated $14.9M sold.

Piedmont Investment Advisors first reported a position in BMY in Q2 2013 and held it in 28 quarters. The position peaked at $71.4M in Q2 2016. 2,190 funds tracked by Wall St. Rank hold BMY as of Q2 2020.

  • Piedmont Investment Advisors reported no remaining Bristol-Myers Squibb position as of Q2 2020 after selling out during the quarter.
  • Piedmont Investment Advisors sold 267,629 Bristol-Myers Squibb shares in Q2 2020, an estimated $14.9M.
  • Piedmont Investment Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 28 quarters.
  • Piedmont Investment Advisors's Bristol-Myers Squibb position peaked at $71.4M in Q2 2016.
  • 2,190 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2020.

Based on Piedmont Investment Advisors's 13F filing for Q2 2020.